Clinical Trial Update: Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of dalpiciclib combined with letrozole as neoadjuvant therapy for stage II-III HR-positive/HER2-negative breast cancer is in early stages w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• Letrozole (letrozole)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Solid Tumor | Phase 2 | Status: UNKNOWN